Business Wire

rf IDEAS celebrates 25 years of identity access management innovation.

30.4.2020 23:48:00 EEST | Business Wire | Press release

Share

As a leader in the identity access management industry, rf IDEAS welcomes its 25th year in business with a refreshed brand, revamped website, and new products in the WAVE ID® line of proximity and contactless identification, mobile credential and authentication readers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200430006013/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

WAVE ID® Nano USB-C (Photo: Business Wire)

A tradition of progressive product development and exceptional customer service is demonstrated in long-lasting partnerships with Imprivata, HP, and Google. "Collaboration is the key to our growth and leadership in the identity access management market," says David Cottingham, president of rf IDEAS. "Our new products—including great strides in contactless authentication—reflect our drive to create market solutions that anticipate and deliver on the changing needs of customers."

The redesigned rfIDEAS.com website guides customers to the ideal solution for applications such as employee identification, secure printing, time and attendance, and other areas, with biometric authentication solutions coming soon.

The company’s newest single sign-on solution, WAVE ID® Nano USB-C, delivers the same wireless reader technology now available in the fast-growing Type-C USB connector, in a design that stands up to hostile environments. It makes reader capabilities possible on smaller devices and is compatible with Apple, Google, and Microsoft USB-C enabled devices, clinician laptops, and mobility applications.

The company’s commitment to innovation and quality ensures that all processes, product quality control, development and overall corporate management meet and exceed customer expectations. As a result, rf IDEAS was listed for five consecutive years (2011 through 2015) on Inc. magazine's list of America's Fastest-Growing Private Companies prior to its acquisition in 2015 by Roper Technologies, Inc. New branding and product lines continue to reflect this dedication to thought leadership and innovation.

About rf IDEAS

rf IDEAS, Inc. is a leader in the card and credential reader space for healthcare, manufacturing, government, and enterprise. Partnering with leading technology companies, rf IDEAS readers enable innovative solutions for single sign-on, secure printing, attendance tracking, and other applications that require authentication. rf IDEAS readers support nearly all credential technologies worldwide and the growing set of mobile credentials. For more information, visit www.rfideas.com.

rf IDEAS® is a registered trademark of rf IDEAS, Inc. All other trademarks, service marks and product or service names are property of their respective owners

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contact
Arlene King
Marketing Manager
Ph: (866) 439-4884 Ext: 480
E: Marketing@RFIDeas.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim2.9.2026 15:00:00 EEST | Press release

Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenvironment of a gene target through its MOSAIC dataset. Under the new agreement, Owkin will license multimodal oncology data to Boehringer and will generate new multimodal data in immunology. Owkin licenses, sources and generates multimodal patient data in collaboration with its global patient data network. Boehringer Ingelheim’s teams will access and analyze this data through K Pro, which provides a single environment to interrogate data and run reproducible analyses. K Pro’s reasoning capabilities supp

Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience2.9.2026 15:00:00 EEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VHH antibody molecule was generated from Biocytogen’s proprietary RenNano® platform. The RenNano® platform is designed to discover fully human VHH antibody molecules with favorable specificity, binding affinity, and developability, and can generate molecular building blocks for the design and development of VHH antibodies, bispecific/multispecific antibodies, antibody-drug conjugates, and other innovative modalities. Through this license, Qilu Pharmaceutical may advance the research and development o

Croma-Pharma Introduces Electronic Instructions for Use Across the saypha ® Portfolio2.9.2026 14:37:00 EEST | Press release

Croma-Pharma has introduced electronic Instructions for Use (eIFU) across its saypha® portfolio in markets where applicable regulations permit electronic Instructions for Use to replace printed versions. The transition expands digital access to essential product information for healthcare professionals while reducing the use of printed documentation. Healthcare professionals can access the current approved Instructions for Use by scanning the QR code on the saypha® folding box. The eIFU platform provides direct digital access to the latest approved Instructions for Use. "Innovation extends beyond product development. It also includes how we provide healthcare professionals with access to essential product information," said Andreas Prinz, Chief Executive Officer of Croma-Pharma. "The introduction of electronic Instructions for Use across the saypha® portfolio reflects our focus on practical digital solutions that support healthcare professionals and align with evolving regulatory requi

Moving Forward in Oman: Orascom, Samih Sawiris and Muriya Keep Building2.9.2026 14:13:00 EEST | Press release

Across Oman, Orascom Development and its Sultanate platform, Muriya, are moving forward. While parts of the region grow cautious, Muriya has paused nothing, building and delivering across all three destinations: Hawana Salalah, Jebel Sifah and As Sodah Island. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260902781576/en/ Moving Forward in Oman: Orascom, Samih Sawiris and Muriya Keep Building (Photo: AETOSWire) The same steadiness runs through everything Samih Sawiris and Orascom have built, from El Gouna to Andermatt to Mamula Island: identifying extraordinary places and developing them for the long term. “Oman has everything we look for as a long-term developer: stability, natural beauty, and a clear direction for its future. Our continued investment across all three destinations reflects that conviction — we build for decades, and Oman is a country we intend to grow with in all circumstances.” — Naguib S. Sawiris, Chairm

Aukera Closes €460 Million Structured Credit Facility Led by EIG to Support European Energy Infrastructure Portfolio2.9.2026 14:00:00 EEST | Press release

Aukera, the pan-European battery storage and renewable energy platform backed by AtlasInvest, Reggeborgh and SFPIM (Belgium's sovereign wealth fund), announced the closing of its €460 million structured credit facility, for which EIG, a leading institutional investor in the global energy and infrastructure sectors, served as the lead investor. With the financing in place, Aukera moves into its next phase of growth, combining capital, expertise and delivery capability to build a significant European energy infrastructure platform that develops, finances, constructs and operates assets at scale. The original facility included an initial €200 million commitment and an accordion feature of up to €250 million. The amended facility converts that accordion into a firmly committed €260 million Series 2 tranche, increasing total committed capital to €460 million. The additional capital will support the continued advancement of Aukera's portfolio of renewable energy generation, battery storage a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye